High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia.

Hagop Kantarjian; Moshe Talpaz; Susan O'Brien; Guillermo Garcia-Manero; Srdan Verstovsek; Francis Giles; Mary Beth Rios; Jianqin Shan; Laurie Letvak; Deborah Thomas

doi:10.1182/blood-2003-11-3800

High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia.

Identifier:nobleid.org/w1/20260515/FDC44FC7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FDC44FC7.svg?ark=w1%2F20260515%2FFDC44FC7)](https://nobleid.org/work/w1/20260515/FDC44FC7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Hagop Kantarjian

Moshe Talpaz

Susan O'Brien

Guillermo Garcia-Manero

Claim authorship of this work

High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia.

Identifier:nobleid.org/w1/20260515/FDC44FC7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FDC44FC7.svg?ark=w1%2F20260515%2FFDC44FC7)](https://nobleid.org/work/w1/20260515/FDC44FC7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Hagop Kantarjian

Moshe Talpaz

Susan O'Brien

Guillermo Garcia-Manero

Claim authorship of this work